# Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands

> **NCT02602275** · PHASE2 · COMPLETED · sponsor: **Biologische Heilmittel Heel GmbH** · enrollment: 53 (actual)

## Conditions studied

- Acute Stress Reaction

## Interventions

- **DRUG:** Neurexan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02602275
- **Lead sponsor:** Biologische Heilmittel Heel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602275, "Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02602275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*